CTMX Annual Revenue
$101.21 M
+$48.05 M+90.38%
31 December 2023
Summary:
As of January 23, 2025, CTMX annual revenue is $101.21 million, with the most recent change of +$48.05 million (+90.38%) on December 31, 2023. During the last 3 years, it has risen by +$32.79 million (+47.92%). CTMX annual revenue is now at all-time high.CTMX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTMX Quarterly Revenue
$33.43 M
+$8.32 M+33.12%
30 September 2024
Summary:
As of January 23, 2025, CTMX quarterly revenue is $33.43 million, with the most recent change of +$8.32 million (+33.12%) on September 30, 2024. Over the past year, it has increased by +$7.05 million (+26.71%). CTMX quarterly revenue is now -32.59% below its all-time high of $49.59 million, reached on March 31, 2020.CTMX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTMX TTM Revenue
$126.62 M
+$7.05 M+5.89%
30 September 2024
Summary:
As of January 23, 2025, CTMX TTM revenue is $126.62 million, with the most recent change of +$7.05 million (+5.89%) on September 30, 2024. Over the past year, it has increased by +$31.89 million (+33.66%). CTMX TTM revenue is now at all-time high.CTMX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTMX Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +90.4% | +26.7% | +33.7% |
| 3 y3 years | +47.9% | +26.7% | +33.7% |
| 5 y5 years | +70.1% | +26.7% | +33.7% |
CTMX Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +171.3% | -19.4% | +366.7% | at high | +517.5% |
| 5 y | 5-year | at high | +276.2% | -32.6% | +249.9% | at high | +517.5% |
| alltime | all time | at high | >+9999.0% | -32.6% | +249.9% | at high | +6511.9% |
CytomX Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $33.43 M(+33.1%) | $126.62 M(+5.9%) |
| June 2024 | - | $25.11 M(-39.4%) | $119.57 M(+0.3%) |
| Mar 2024 | - | $41.46 M(+55.8%) | $119.18 M(+17.7%) |
| Dec 2023 | $101.21 M(+90.4%) | $26.61 M(+0.8%) | $101.21 M(+6.8%) |
| Sept 2023 | - | $26.38 M(+6.7%) | $94.73 M(+19.2%) |
| June 2023 | - | $24.72 M(+5.2%) | $79.49 M(+17.6%) |
| Mar 2023 | - | $23.50 M(+16.8%) | $67.62 M(+27.2%) |
| Dec 2022 | $53.16 M(+42.5%) | $20.12 M(+80.5%) | $53.16 M(+159.3%) |
| Sept 2022 | - | $11.15 M(-13.3%) | $20.51 M(-23.9%) |
| June 2022 | - | $12.85 M(+42.2%) | $26.95 M(-11.3%) |
| Mar 2022 | - | $9.04 M(-172.1%) | $30.38 M(-18.6%) |
| Dec 2021 | $37.31 M(-45.5%) | -$12.53 M(-171.3%) | $37.31 M(+8.8%) |
| Sept 2021 | - | $17.59 M(+8.0%) | $34.28 M(-0.6%) |
| June 2021 | - | $16.29 M(+2.0%) | $34.48 M(-0.9%) |
| Mar 2021 | - | $15.97 M(-202.6%) | $34.80 M(-49.1%) |
| Dec 2020 | $68.43 M(+154.4%) | -$15.56 M(-187.5%) | $68.43 M(+10.9%) |
| Sept 2020 | - | $17.79 M(+7.1%) | $61.68 M(+13.0%) |
| June 2020 | - | $16.61 M(-66.5%) | $54.60 M(+16.2%) |
| Mar 2020 | - | $49.59 M(-322.3%) | $47.01 M(+74.7%) |
| Dec 2019 | $26.90 M | -$22.31 M(-308.3%) | $26.90 M(-55.7%) |
| Sept 2019 | - | $10.71 M(+18.9%) | $60.68 M(-2.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2019 | - | $9.01 M(-69.4%) | $62.48 M(-16.5%) |
| Mar 2019 | - | $29.48 M(+157.0%) | $74.80 M(+25.7%) |
| Dec 2018 | $59.50 M(-16.9%) | $11.47 M(-8.3%) | $59.50 M(-20.8%) |
| Sept 2018 | - | $12.51 M(-41.4%) | $75.10 M(-13.4%) |
| June 2018 | - | $21.34 M(+50.4%) | $86.74 M(+17.0%) |
| Mar 2018 | - | $14.18 M(-47.6%) | $74.15 M(+3.5%) |
| Dec 2017 | $71.62 M(+376.1%) | $27.07 M(+12.1%) | $71.62 M(+40.9%) |
| Sept 2017 | - | $24.14 M(+175.9%) | $50.82 M(+68.7%) |
| June 2017 | - | $8.75 M(-24.9%) | $30.13 M(+23.1%) |
| Mar 2017 | - | $11.65 M(+85.8%) | $24.47 M(+62.7%) |
| Dec 2016 | $15.04 M(+95.1%) | $6.27 M(+81.6%) | $15.04 M(+39.8%) |
| Sept 2016 | - | $3.45 M(+11.6%) | $10.76 M(+16.4%) |
| June 2016 | - | $3.09 M(+39.2%) | $9.24 M(+12.8%) |
| Mar 2016 | - | $2.22 M(+11.8%) | $8.19 M(+6.2%) |
| Dec 2015 | $7.71 M(+51.9%) | $1.99 M(+2.5%) | $7.71 M(+1.7%) |
| Sept 2015 | - | $1.94 M(-5.1%) | $7.58 M(+0.3%) |
| June 2015 | - | $2.04 M(+17.3%) | $7.56 M(+37.0%) |
| Mar 2015 | - | $1.74 M(-6.4%) | $5.52 M(+46.1%) |
| Dec 2014 | $5.08 M(+471.7%) | $1.86 M(-2.8%) | $3.78 M(+97.2%) |
| Sept 2014 | - | $1.92 M | $1.92 M |
| Dec 2013 | $888.00 K | - | - |
FAQ
- What is CytomX Therapeutics annual revenue?
- What is the all time high annual revenue for CytomX Therapeutics?
- What is CytomX Therapeutics annual revenue year-on-year change?
- What is CytomX Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for CytomX Therapeutics?
- What is CytomX Therapeutics quarterly revenue year-on-year change?
- What is CytomX Therapeutics TTM revenue?
- What is the all time high TTM revenue for CytomX Therapeutics?
- What is CytomX Therapeutics TTM revenue year-on-year change?
What is CytomX Therapeutics annual revenue?
The current annual revenue of CTMX is $101.21 M
What is the all time high annual revenue for CytomX Therapeutics?
CytomX Therapeutics all-time high annual revenue is $101.21 M
What is CytomX Therapeutics annual revenue year-on-year change?
Over the past year, CTMX annual revenue has changed by +$48.05 M (+90.38%)
What is CytomX Therapeutics quarterly revenue?
The current quarterly revenue of CTMX is $33.43 M
What is the all time high quarterly revenue for CytomX Therapeutics?
CytomX Therapeutics all-time high quarterly revenue is $49.59 M
What is CytomX Therapeutics quarterly revenue year-on-year change?
Over the past year, CTMX quarterly revenue has changed by +$7.05 M (+26.71%)
What is CytomX Therapeutics TTM revenue?
The current TTM revenue of CTMX is $126.62 M
What is the all time high TTM revenue for CytomX Therapeutics?
CytomX Therapeutics all-time high TTM revenue is $126.62 M
What is CytomX Therapeutics TTM revenue year-on-year change?
Over the past year, CTMX TTM revenue has changed by +$31.89 M (+33.66%)